🔗 Share this article

As the US undertakes sweeping revisions to its vaccination recommendations, one figure appears in a surprising turn: Høeg, an American of Danish descent sports medicine doctor and epidemiologist who first made her name by expressing skepticism about coronavirus vaccinations in the pandemic and has concentrated on possible deaths after COVID-19 immunization in her short time at the FDA.

Proposed Shifts to Pediatric Immunization Schedule

Public health authorities had intended to reveal major revisions to the pediatric immunization program earlier this month, synchronizing the US with the Danish immunization schedule, sources say – a substantial departure that would put the US at odds with many the international standard with no evidence for public health gain. The planned update has been pushed back until the coming year.

Rather than the director of the vaccine center, Tracy Beth Høeg is listed to address the audience at the meeting. She was just designated interim head of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth appointee to run the division this calendar year.

A New Direction at the FDA

Høeg's temporary position could signify a strengthened alliance between the drug and biologics divisions as Høeg and Dr. Prasad strengthen their influence at the regulatory agency – and it points to a increased emphasis upon dismantling long-standing immunizations at the FDA.

Dr. Høeg has often pushed for discontinuing specific childhood vaccine recommendations in the US so as to align more like Denmark's approach, a country with universal health coverage and a population about the size of Wisconsin’s.

In her initial comments, she has continued to focus on vaccines – typically the responsibility of Prasad, chief of the FDA’s vaccine center – as opposed to medication approval.

Doubts Over Background

The appointee has little discernible experience in drug development, approval processes or leadership, which has been typical for former directors of the biologics center. She has been employed at the FDA as a top consultant to the commissioner and CBER since earlier this year.

“She appears not to have the requisite experience” for overseeing the drug-regulation department, remarked a neurologist and psychiatrist. “She has not conducted a scientific study. She has no expertise in managing a sizeable institution. She has no expertise in drug approvals.”

Previous heads of the center would “grasp legal statutes and the underlying principles of drug development”, said a former acting FDA commissioner. “Frankly, she has not acquired the type of experience that prior appointees who headed CBER have had.”

This division has an immense range of responsibilities at the FDA, the former commissioner emphasized.

“Everybody just zeroes in on the novel medication approvals, but the generic program authorizes a multitude of off-brand pharmaceuticals. There’s a biosimilars program, non-prescription drug unit and other areas, and each of these need to be looked after,” she said. “The thing you overlook, that’s the thing that I always told people is going to cause problems.”

There is also, a major administrative element to the role, which supervises in excess of 5,000 staff members. “It’s a massive administrative position, if you do it right,” she said.

Official Statement and Controversial Policies

Regarding concerns about Dr. Høeg's credentials and whether this appointment represents increased cooperation among agency officials on vaccines, a representative said that the “questions are based on inaccurate premises”.

“Her resume aligns with the functions of her position,” the representative explained, pointing to the months Høeg spent counseling the FDA commissioner on “drug safety and oversight research, including predictive safety algorithms and immunization monitoring”.

As the temporary head, Dr. Høeg assumes responsibility for the commissioner’s controversial priority voucher program, a controversial rapid medication authorization process that allegedly concerned her predecessors. “How are these therapies being picked for this expedited pathway? Who makes the calls?” Dr. Howard questioned. “There’s a lot of lack of transparency happening at the agency right now.”

Overall, he stated, “the agency looks to be trending towards more relaxed regulations of most medications, with the exception of immunizations.”

Documented Past Work on Immunizations

Regarding vaccines, Høeg has a more established, if concerning, past, Howard observe. She released a analysis using non-validated public submissions to determine the incidence of heart inflammation following COVID-19 vaccination. She advised the state of Florida top health official Dr. Joseph Ladapo, who allegedly have altered data to suggest Covid vaccinations are pose a greater threat than they are.

Included in her “desired changes” for the new government included revising rules for recently developed shots and halting “optional” immunizations, she stated after the election on a audio program. At the agency, Høeg has reportedly proposed preventing adolescent males from getting Covid vaccinations.

“She’s an complete dogmatist who starts off with her beliefs and tailors the evidence to accommodate the data in a very misleading, dishonest manner,” Dr. Howard argued.

Consolidating Power and a “Push for Payback”

Dr. Høeg became part of fellow skeptics, {like|